Oseltamivir- resistant pandemic (h1n1) 2009 treated with nebulized zanamivir

Emerging Infectious Diseases

Volumn 16, Issue 11, 2010, Pages 1813-1815

  da Dalt, Liviana ^a   Calistri, Arianna ^a   Chillemi, Chiara ^a   Cusinato, Riccardo ^b   Franchin, Elisa ^a,b   Salata, Cristiano ^a   Sgarabotto, Dino ^b   Toscano, Giuseppe ^b   Gambino, Antonio ^b   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PROTEIN H275Y; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZANAMIVIR;

ANTIVIRAL RESISTANCE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEVER; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETTER; LUNG INFILTRATE; MALE; NEBULIZATION; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VIRUS DETECTION;

CHILD, PRESCHOOL; DOSAGE FORMS; DRUG RESISTANCE, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MUTATION; NEBULIZERS AND VAPORIZERS; OSELTAMIVIR; PANDEMICS; ZANAMIVIR;

EID: 77958559579     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1611.100789     Document Type: Letter

References (8)

1. Centers for Disease Control and Prevention. World Health Organization. Pandemic (H1N1) 2009, update 91. 2010 Mar 12 [cited 2010 Mar 23]. http://www.who.int/ csr/don/2010_03_12/en/index.html.
2. Centers for Disease Control and Prevention. Oseltamivir-resistant novel infl uenza A (H1N1) virus infection in two immunosuppressed patients. MMWR Morb Mortal Wkly Rep. 2009;58:893-6.
3. Halasa NB. Update on the 2009 pandemic infl uenza A H1N1 in children. Curr Opin Pediatr. 2010;22:83-7. DOI: 10.1097/ MOP.0b013e3283350317.
4. Kidd IM, Down J, Nastouli E, Shulman R, Grant PR, Howell DC, et al. H1N1 pneumonitis treated with intravenous zanamivir. Lancet. 2009;374:1036. DOI: 10.1016/S0140-6736(09)61528-2.
5. Gaur AH, Bagga B, Barman S, Hayden R, Lamptey A, Hoffman JM, et al. Intravenous zanamivir for oseltamivirresistant 2009 H1N1 infl uenza. N Engl J Med. 2010;362:88-9. DOI: 10.1056/NEJMc0910893.
6. Dulek DE, Williams JV, Creech CB, Schulert AK, Frangoul HA, Domm J, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically ill immunosuppressed child infected with 2009 pandemic infl uenza A (H1N1) virus. Clin Infect Dis. 2010;50:1493-6. DOI: 10.1086/652655.
7. Cheer SM, Wagstaff A. Spotlight on zanamivir in infl uenza. Am J Respir Med. 2002;1:147-52.
8. Hindiyeh M, Ram D, Mandelboim M, Meningher T, Hirsh S, Robinov J, et al. Rapid detection of infl uenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time RTPCR. J Clin Microbiol. 2010;48:1884-7. DOI: 10.1128/JCM.02540-09.